NEW YORK (Reuters) - U.S. drugmakers Pfizer Inc and Merck & Co posted better-than-expected first-quarter profit and revenue on Tuesday, but Merck gave a 2010 earnings forecast that could fall short of Wall Street’s target.
NEW YORK (Reuters) - U.S. drugmakers Pfizer Inc and Merck & Co posted better-than-expected first-quarter profit and revenue on Tuesday, but Merck gave a 2010 earnings forecast that could fall short of Wall Street’s target.
